Boehringer-Ingelheim Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients. BiomX, Boehringer Ingelheim Partner for Inflammatory Bowel Disease Biomarker Discovery Under the agreement, Israel’s BiomX will generate metagenomic data for gut microbiome samples from IBD patients using its XMarker biomarker discovery platform. TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Keytruda and Ibrance demonstrate activity in molecularly defined populations, while a new cohort will explore Gilotrif in tumors with NRG1 fusions. Boehringer Ingelheim, GNA Biosolutions Partner on African Swine Fever Dx The firms are focusing on developing a rapid diagnostic test for African swine fever that can be used on GNA's portable MDx platform. Qiagen Gets FDA OK for Expanded Use of EGFR CDx for Lung Cancer Drug An extended labeling claim has added detection of three additional EGFR mutations to help ID NSCLC patients for whom Boehringer Ingelheim's Gilotrif is indicated. Oct 12, 2017 NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative Jun 6, 2017 New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer Premium Feb 8, 2017 Penn Medicine Gets $3M From Pharma Consortium for Diabetic Kidney Disease Study Oct 24, 2016 Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients Premium Apr 27, 2015 Survey Shows More NSCLC Patients Getting EGFR Testing, but Results Often Don't Inform Care Premium Nov 13, 2014 Gilotrif Survival Data for Del19 and L858R Patients has Implications for Treatment, Research Premium Oct 31, 2014 Boehringer Ingelheim Taps IDBS’ E-WorkBook Suite to Support R&D Premium Sep 24, 2014 With Boehringer Support, NCCN Awards Grants to Advance Evidence-based Development of Nintedanib Premium Nov 6, 2013 Drugmakers in Third Quarter Focus on Uptake of Newer Personalized Rx to Replace Older Versions Premium Sep 25, 2013 Boehringer Enlists Roche Subsidiary Ventana for Companion Dx Help Premium Sep 19, 2013 Ventana, Boehringer Ingelheim to Collaborate on CDx for Cancer Drugs Sep 4, 2013 After FDA Approval, Boehringer Ingelheim Launching PGx NSCLC Drug Gilotrif in US Premium Sep 3, 2013 Diaxonhit, Boehringer Ingelheim Collaborate on Cancer Therapeutic Targets Aug 14, 2013 Roche's HER2 Breast Cancer Segment Tops List of PGx Drug Sales in Q2 Premium Jul 18, 2013 Dx Focus: FDA Approves Qiagen Therascreen EGFR RGQ; Luminex xTAG CYP2D6 Kits Premium Jul 17, 2013 FDA Okays Boehringer's Gilotrif, Qiagen EGFR Test, Providing New PGx Options for Advanced NSCLC Premium Jul 12, 2013 FDA Approves Qiagen's Therascreen EGFR as CDx for Boehringer Ingelheim's NSCLC Drug May 15, 2013 Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx Premium Feb 15, 2013 Boehringer Ingelheim to Use ChemAxon's Cheminformatics Software for Drug Research Premium Jan 16, 2013 Pharmas and Dx Partners Race to Launch the First Personalized EGFR Inhibitor for Lung Cancer Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.